Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
Become a Member | Sign in
Home>News>This Article

TAP Biosystems Presents New Data on 3D Cell Culture Research

Published: Monday, January 20, 2014
Last Updated: Sunday, January 19, 2014
Bookmark and Share
Discussing the application of RAFT 3D models in oncology, toxicology and neuroscience cell-based screening programmes.

TAP Biosystems has announced that it will be giving two presentations on its RAFT 3D cell culture system at the Society for Laboratory Automation and Screening (SLAS) Conference in San Diego.

Senior applications specialists will discuss how 3D models are being used to improve oncology, neuroscience and toxicology research programmes and present the latest research data.

TAP is presenting a lunchtime tutorial entitled: “Use of 3D cell culture in oncology research” which will be hosted by Dr Grant Cameron, TAP Biosystems’ RAFT Development Director in room 28a between 12.30-1.15pm on Monday January 20th.

The presentation will include details on how 3D cultures with tissue-like, physiologically relevant concentrations of cells and collagen are generated without using complex chemistry, cross linking agents or extended culture periods.

The talk will provide new data showing how cancer cell lines cultured with the RAFT system are used to generate dose response curves, as well as study cell signalling, target modulation and mitochondrial function. It will also focus on new data showing the use of human primary and iPSC hepatocytes with the RAFT system.

Spaces at this tutorial are limited and researchers wanting to attend should click the link to register.

Also on Monday January 20th there will be a podium presentation from 3.00-3.30pm by Dr Rosemary Drake, TAP Biosystems’ Chief Scientific Officer as part of the scaling up microfluidics diagnostics session.

Entitled “Collagen Engineering for Simple, Consistent Production of Complex Model Tissues for Drug Discovery - Stem Cell Niche in a Dish”, it will show how the RAFT process generates defined, spatial assembly of cells and extracellular matrix simply and consistently, and will discuss the importance and influence of the microenvironment on cell behaviour, including iPSC. It will describe engineering the stem cell niche of the cornea, by creating topography in a rapid one step process. It will also discuss methods and tools for aligning the collagen matrix and cells to produce more realistic neural system models and will illustrate the wide applicability of RAFT 3D cell cultures across drug discovery research and screening.

Dr Grant Cameron, TAP Biosystems’ RAFT Development Director commented: “3D cell culture permits more complex systems to be studied and provides greater insights into complex cellular interactions and more physiologically relevant data than conventional 2D systems. Our presentations at SLAS explain how RAFT generated 3D constructs with simple or complex topography can be rapidly produced in standard plates at a scale appropriate for drug discovery. Researchers looking to incorporate reproducible 3D cell cultures into their oncology or toxicology cell-based screening programmes for example, should attend our presentations at SLAS or come and see the simple to use, RAFT system in action on Booth 520.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck and TAP Biosystems Finalists for “Best Collaboration Award”
Recognizing ambr250 as a breakthrough technology for process development.
Wednesday, October 08, 2014
TAP and Gallus Co-host Free Webinar
Explaining the benefits of using ambr15 microbioreactors for DoE.
Wednesday, October 01, 2014
New Webinars Explore Feed Strategy Challenges Using Mini Bioreactors
Detailing how to achieve consistent feeding regimes for reproducible scale-up.
Thursday, September 25, 2014
New Webinar on Mimicking Perfusion Culture Using Micro Bioreactors
Presents validation data for improving media screening and process optimization.
Friday, February 14, 2014
Collaboration between TAP Biosystems and UCL to Develop Biomimetic 3D Cancer Models
TAP Biosystems announced new collaboration to develop solid tumour tissue models using its RAFT 3D cell culture system for use in drug discovery applications.
Friday, October 12, 2012
Scientific News
Novel Tumor Treatment
In the first published results from a $386,000 National Cancer Institute grant awarded earlier this year, a paper by Scott Verbridge and Rafael Davalos has been published.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Some Gut Microbes May Be Keystones of Health
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Tissue Engineers Recruit Cells to Make Their Own Strong Matrix
Extracellular matrix is the material that gives tissues their strength and stretch. It’s been hard to make well in the lab, but a Brown University team reports new success. The key was creating a culture environment that guided cells to make ECM themselves.
Towards Patient-Specific Drug Screening
A new breakthrough by the 3D stem cell printing team at Heriot-Watt could pave the way to individually tailored drug testing regimes, both reducing the need for animal testing and ensuring that patients receive drugs which are most effective for their individual needs.
Artificial Kidney Research Gets A Boost
Development of a surgically implantable, artificial kidney — a promising alternative to kidney transplantation or dialysis for people with end-stage kidney disease — has received a $6 million boost.
Improving the Efficiency of Red Blood Cell Production
Study points to way of significantly reducing cost of laboratory-produced cells.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos